Hedge Fund - Cormorant Asset Management
Neurocrine Biosciences Inc (NBIX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2020 - Q2 (2020-06-30) | $0 | 0% | 0 | $110.51 |
| 2 | 2020 - Q1 (2020-03-31) | $2,164,000 | 0.1% | 25,000 | $97.87 |
| 3 | 2019 - Q4 (2019-12-31) | $4,224,000 | 0.16% | 39,300 | $104.70 |
| 4 | 2019 - Q3 (2019-09-30) | $3,541,000 | 0.21% | 39,300 | $93.43 |
| 5 | 2019 - Q2 (2019-06-30) | $4,222,000 | 0.24% | 50,000 | $82.11 |
| 6 | 2019 - Q1 (2019-03-31) | $7,929,000 | 0.53% | 90,000 | $83.58 |
| 7 | 2018 - Q4 (2018-12-31) | $15,583,000 | 1.26% | 218,222 | $95.81 |
| 8 | 2018 - Q3 (2018-09-30) | $21,516,000 | 1.39% | 175,000 | $113.46 |
| 9 | 2018 - Q2 (2018-06-30) | $18,775,000 | 1.38% | 191,112 | $89.51 |
| 10 | 2018 - Q1 (2018-03-31) | $15,849,000 | 1.18% | 191,112 | $84.45 |
| 11 | 2017 - Q4 (2017-12-31) | $15,518,000 | 1.62% | 200,000 | $68.21 |
| 12 | 2017 - Q3 (2017-09-30) | $15,320,000 | 2.7% | 250,000 | $52.77 |
| 13 | 2017 - Q2 (2017-06-30) | $11,500,000 | 1.9% | 250,000 | $48.51 |
| 14 | 2017 - Q1 (2017-03-31) | $12,990,000 | 1.88% | 300,000 | $42.84 |
| 15 | 2016 - Q4 (2016-12-31) | $13,893,000 | 1.87% | 359,000 | $45.27 |
| 16 | 2016 - Q3 (2016-09-30) | $20,170,000 | 2.22% | 398,301 | $49.80 |
| 17 | 2016 - Q2 (2016-06-30) | $18,103,000 | 2.56% | 398,301 | $46.04 |
| 18 | 2016 - Q1 (2016-03-31) | $23,884,000 | 1.2% | 603,900 | $39.68 |
| 19 | 2015 - Q4 (2015-12-31) | $34,163,000 | 4.08% | 603,900 | $50.83 |
| 20 | 2015 - Q3 (2015-09-30) | $28,605,000 | 4.56% | 718,900 | $48.33 |
| 21 | 2015 - Q2 (2015-06-30) | $34,335,000 | 4.56% | 718,900 | $42.40 |
| 22 | 2015 - Q1 (2015-03-31) | $28,548,000 | 4.41% | 718,900 | $35.77 |
| 23 | 2014 - Q4 (2014-12-31) | $22,340,000 | 3.44% | 1,000,000 | $18.95 |
The displayed share prices are average quarterly stock market prices.